Home
Register
Login
Add a New Patient
Patient Entry
Patient ID:
Diagnosis Age:
Sex:
Male
Female
Race:
American Indian or Alaska Native
Asian
Black/African American
Native Hawaiian/Other Pacific Islander
White
None
Patient Weight:
Cancer Entry
Oncotree Code:
UEC
USC
UMEC
None
Cancer Type Detail:
Uterine Endometrioid Carcinoma
Uterine Mixed Endometrial Carcinoma
Uterine Serous Carcinoma/Uterine Papillary Serous Carcinoma
None
Tumor Type:
Endometrioid Endometrial Adenocarcinoma
Mixed Serous and Endometrioid Carcinoma
Serous Endometrial Adenocarcinoma
None
Grade:
G1
G2
G3
HIGH GRADE
None
Tissue Source Site Code:
Aneuploidy Score:
Msi Score Mantis:
Msi Sensor Score:
Tmb Nonsynonymous:
Method Of Sample Procurement:
Surgical Resection
Hystorectomy Nos
Endoscopic Biopsy
Excisional Biopsy
None
Tumor Necrosis Percent:
Tumor Nuclei Percent:
Tumor Weight:
Vessel Used:
50Ml Conical
Biospecimen Storage Bag
Cassette
Cryomold
Cryovial
Freezer Cup
Specimen Storage Bag
Other
None
Treatment Entry
Radiation Therapy:
Yes
No
None
Treatment Start Date For Treatment 1:
Treatment Stop Date For Treatment 1:
Treatment for treatment 1:
Chemotherapy
Radiation Therapy
Hormone Therapy
Targeted Molecular Therapy
Not Specified
None
Agent for treatment 1:
Number Of Cycles for treatment 1:
Dosage for treatment 1:
Dosage Unit for treatment 1:
mg/m2
mg
auc
mg/day
mg/ml
mg/m2/day
None
Regimen Number for treatment 1:
Regimen Indication for treatment 1:
Response Measurement for treatment 1:
Drug Classification for treatment 1:
adjuvent
radiation alone
None
Administration for treatment 1:
Therapy Ongoing for treatment 1:
Yes
No
None
Total Dosage for treatment 1:
Total Dosage Unit for treatment 1:
mg
mg/m2
[iu]/mg
mg/day
None
Tx On Clinical Trial for treatment 1:
Yes
No
None
Anatomic Site for treatment 1:
Primary Tumor Field
Regional Site
Distant Recurrence
Local Recurrence
Distant Site
None
Course Number for treatment 1:
Number Of Fractions for treatment 1:
Radiation Dosage for treatment 1:
Radiation Treatment Ongoing for treatment 1:
Yes
No
None
Radiation Type for treatment 1:
Implants
External Beam
Internal
External
Combination
Radioisotope
Other
None
Radiation Units for treatment 1:
cgy
gy
None
Status Entry
Last Communication Contact from Initial Pathologic Diagnosis Date:
New Neoplasm Event Post Initial Therapy Indicator:
Yes
No
None
Person Neoplasm Cancer Status:
Tumor Free
With Tumor
None
Overall Survival Status:
Living
Deceased
None
Overall Survival Months:
Disease Specific Survival Status:
ALIVE OR DEAD TUMOR FREE
DEAD WITH TUMOR
None
Months of Disease Specific Survival:
Disease Free Status:
DiseaseFree
Recurred/Progressed
None
Disease Free Months:
Progression Free Status:
Censored
Progression
None
Progress Free Survival Months:
Clinical Stage For Status:
Initial Diagnosis
Last Follow Up
New Primary Tumor
Distant Metastasis
None
Status For Status 2:
Last Follow Up
DECEASED
Metastatic
Locoregional Recurrence
Last Known Alive
Distant Metastasis
New Primary Tumor
Initial Diagnosis
None
Clinical Stage For Status 1:
stage Ia
stage Ib
stage IIIa
stage II
stage IIIc
stage Ic
stage IIIc2
stage IVb
stage IIIc1
stage IIb
stage IIIb
stage IIa
stage IV
stage IVa
stage I
stage III
None
Initial Pathologic Diagnosis Method For Status 1:
Office Endometrial Biopsy
Dilation And Curettage Procedure
Tumor Resection
Cytology (E.G. Peritoneal Or Pleural Fluid)
Excisional Biopsy
Incisional Biopsy
Fine Needle Aspiration Biopsy
None
Anatomic Site For Status 1:
Tumor Status For Status 1:
TUMOR FREE
WITH TUMOR
None
Primary Therapy Outcome Success For Status 1:
Vital Status For Status 1:
Add